139 related articles for article (PubMed ID: 10696532)
1. Effect of uranyl nitrate-induced renal failure on morphine disposition and antinociceptive response in rats.
Van Crugten JT; Somogyi AA; Nation RL
Clin Exp Pharmacol Physiol; 2000; 27(1-2):74-9. PubMed ID: 10696532
[TBL] [Abstract][Full Text] [Related]
2. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
3. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
[TBL] [Abstract][Full Text] [Related]
4. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.
Smith GD; Smith MT
Pain; 1995 Jul; 62(1):51-60. PubMed ID: 7478708
[TBL] [Abstract][Full Text] [Related]
5. The influence of hemorrhagic shock on the pharmacokinetics and the analgesic effect of morphine in the rat.
De Paepe P; Belpaire FM; Rosseel MT; Buylaert WA
Fundam Clin Pharmacol; 1998; 12(6):624-30. PubMed ID: 9818295
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
7. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
[TBL] [Abstract][Full Text] [Related]
8. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats.
Baker L; Ratka A
Pain; 2002 Jan; 95(1-2):65-74. PubMed ID: 11790468
[TBL] [Abstract][Full Text] [Related]
10. Morphine-induced analgesia in rats withdrawn from concurrent nimodipine and morphine treatment.
Zharkovsky A; Katajamäki J; Seppälä T; Ahtee L
Pain; 1999 Feb; 79(2-3):217-22. PubMed ID: 10068167
[TBL] [Abstract][Full Text] [Related]
11. Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception.
Ouellet DM; Pollack GM
Biochem Pharmacol; 1997 May; 53(10):1451-7. PubMed ID: 9260872
[TBL] [Abstract][Full Text] [Related]
12. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
14. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
15. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Pharm Res; 1998 Apr; 15(4):599-605. PubMed ID: 9587957
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine.
Ekblom M; Gårdmark M; Hammarlund-Udenaes M
Biopharm Drug Dispos; 1993 Jan; 14(1):1-11. PubMed ID: 8427941
[TBL] [Abstract][Full Text] [Related]
18. Morphine Glucuronidation and Elimination in Intensive Care Patients: A Comparison with Healthy Volunteers.
Ahlers SJ; Välitalo PA; Peeters MY; Gulik Lv; van Dongen EP; Dahan A; Tibboel D; Knibbe CA
Anesth Analg; 2015 Nov; 121(5):1261-73. PubMed ID: 26332855
[TBL] [Abstract][Full Text] [Related]
19. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test.
Lötsch J; Tegeder I; Angst MS; Geisslinger G
Life Sci; 2000 May; 66(24):2393-403. PubMed ID: 10864101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
